Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomas
- 1 March 2006
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 86 (3) , 246-253
- https://doi.org/10.1038/labinvest.3700385
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alphaPublished by Elsevier ,2005
- Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide displayProteomics, 2005
- HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samplesProteomics, 2005
- Correlation-associated peptide networks of human cerebrospinal fluidProteomics, 2005
- Steroid receptors in human breast cancerTrends in Endocrinology & Metabolism, 2004
- Mass Spectrometric Phenotyping of Val34Leu Polymorphism of Blood Coagulation Factor XIII by Differential Peptide DisplayClinical Chemistry, 2004
- Regulation of prothymosin α by estrogen receptor α: molecular mechanisms and relevance in estrogen-mediated breast cell growthOncogene, 2002
- Analysis of Estrogen Receptor Interaction with a Repressor of Estrogen Receptor Activity (REA) and the Regulation of Estrogen Receptor Transcriptional Activity by REAJournal of Biological Chemistry, 2000
- Cloning, Isolation, and Characterization of Mammalian Legumain, an Asparaginyl EndopeptidaseJournal of Biological Chemistry, 1997
- Prothymosin α binds to histone H1 in vitroFEBS Letters, 1994